Welcome to LookChem.com Sign In|Join Free

CAS

  • or

126798-27-4

Post Buying Request

126798-27-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

126798-27-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 126798-27-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,7,9 and 8 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 126798-27:
(8*1)+(7*2)+(6*6)+(5*7)+(4*9)+(3*8)+(2*2)+(1*7)=164
164 % 10 = 4
So 126798-27-4 is a valid CAS Registry Number.

126798-27-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-methyl-2-oxo-1H-pyridine-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 4-Pyridinecarboxylicacid,1,2-dihydro-3-methyl-2-oxo-(9CI)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:126798-27-4 SDS

126798-27-4Downstream Products

126798-27-4Relevant articles and documents

HIV protease inhibitors

-

, (2008/06/13)

HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.

Intermediate and process for making

-

, (2008/06/13)

The present invention provides novel HIV protease inhibitors, pharmaceutical formulations containing those compounds and methods of treating and/or preventing HIV infection and/or AIDS.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 126798-27-4